Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
After striking a pact to bolster intravenous solution supplies in the U.S. last year, California's ICU Medical has run into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback